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This study was carried out to evaluate the antimicrobial and anti-inflammatory activity of some 
chemical compounds of the volatile oil extracted from Tropaeolum majus L. The chemical compounds 
extracted from the flowers and leaves of T. majus L. have been identified through color reactions and 
gas-chromatographic analysis combined with mass spectrometry. Quantitative testing and the 
ascertaining of the minimum inhibitory concentration (MIC) have been done through the binary micro 
dilution method for liquid environments against the following microbial types and species. The 
qualitative evaluation of the sensitivity of microbial stems against these compounds has been done 
through methods that have been adapted from the diffusimetric method. Of the qualitative methods 
used for the control of the antimicrobial activity, the method of diffusion on filter paper discs proved to 
be the most efficient, the results correlating well with the MIC. Our studies have demonstrated the 
efficiency of the natural compounds’ of T. majus L. in anti-inflammatory treatments in animals. The 
antimicrobial activity proved to be selective, depending on the pathogen. These results are in 
agreement with those of other studies. Our results supported the selection and utilization of these 
compounds’ as antimicrobial agents in the treatment of infections with microorganisms resistant to 
existent antibiotics. 
 





The emergence of the resistance and multiresistance 
phenomena of the infectious agents to antimicrobial 
agents has generated the intensification of research 
efforts to find new antimicrobial agents and to develop 
new strategies to treat infectious disease. Antibiotics are 
used on a wide scale against negative aerobic Gram 
bacilli and positive, atypical and anaerobical Gram 
germs. The emergence of new antibiotics with improved 
pharmacokinetics and bioavailability and with a net 
superior tissular action and diffusion spectrum has 
allowed the enlargement of the clinical indications range. 
Unfortunately, excessive use of antibiotics has led to the 
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cially in the case of first generation antibiotics (Vancanneyt 
et al., 2004). This is why knowing the pharmacodynamic 
properties and the resistance spectre is necessary for the 
judicious use of all antibiotics, in general. Because 
pathogen resistance against antibiotics is so wide spread, 
treatment effectiveness in infectious pathology is more 
and more uncertain. 
For this reason, the past years have seen massive 
efforts in the attempt to identify alternative treatments to 
the classical ways represented by antibiotic therapy. 
A possible solution is using natural products, such as 
volatile oils extracted from various plants (Nair et al., 
2006). Plants have been used in traditional treatments to 
cure various diseases for thousands of years. Numerous 
studies have demonstrated that volatile oils obtained from 
plants represent antibacterial, antifungic, antiviral, insec-
ticide and antioxidant properties (Yoneyama et al., 2006). 





secondary metabolites have been intensely debated 
despite the recognition of their biological activity. Both the 
terpenoids and the phenolic compounds are important in 
the plant’s protection against insects and herbivorous 
animals; in strive to find space and resources against 
competing plants and against pathogen microorganisms 
(Trott et al., 2007). 
Secondary metabolites like the alkaloids, isoprenoids 
and pheolic acids are eliminated as exudates by the 
leaves, on their surface. Volatile oils (also called essential 
oils) are regular aromatic compounds from different parts 
of the plant (flowers, buds, seeds, branches, bark, wood, 
fruit or roots) (Swarna et al., 2009). They can be obtained 
through fermentation or extraction, but the most 
commercially used method is hydro distillation (Silva et 
al., 2005). Volatile oils contain a mix of compounds that 
from a chemical point of view derive from terpenoids or 
their oxygenated compounds. Volatile oil compounds 
have been used in the therapy of certain forms of cancer, 
others in food preservation (active preservation), or as 
source of active biological compounds (Pattnaik et al., 
1997). The largest use of volatile oils in the European 
Union is registered in the food industry (spices), cos-
metics and pharmaceuticals. Their antibacterial propert-
ies and those of their subcomponents have been 
exploited as various commercial products, such as: 
concoctions for the obturation of dental root canals, 
antiseptics, or additives for animal feeds. Because of this, 
we expect to discover that within the chemical compo-
sition of the volatile oils coming from different species of 
plants there are substances with antimicrobial properties 
with specific or general actions against microorganisms. 
Although, the antimicrobial properties of volatile oils and 
their compounds have been researched in the past, the 
mechanism of their action has not been studied in detail 
(Guardabassi et al., 2008). Taking into account the large 
number of the different groups of chemical compounds 
present in the composition of volatile oils, their anti-
microbial activity cannot be assigned to a sole specific 
mechanism. Their activity depends on the process 
through which the volatile oil is obtained, the target 
location and the synergies of the constituent substances. 
The chemical structure of the individual compounds of 
volatile oils affects their specific antibacterial action. A 
characteristic of volatile oils and their compounds is 
hydrophobia, which permits them to affect the lipid 
structure of the bacterial cellular membrane and increase 
its permeability (Dolganiuc et al., 1997). 
The importance of the presence of the hydroxyls 
grouping within the phenolic compounds like carvacrol 
and thymol has been confirmed. The position of this 
grouping within the phenolic ring does not seem to 
significantly affect the degree of antibacterial activity 
(Tzakou et al., 2001). In Romania, the Tropaeolum majus 
is cultivated as a decorative plant. T. majus contains 
glucosynolates, sulphur glicosydes, an antibiotic (tromalyte), 
bensilglucosynolate, glucosinol,  and  glicotropeoline. The 




plant also contains flavonoids, vitamin C, iodide, spilan-
tolic acid, oxalic acid and mirosine (enzymes). 
Glicotropeopline frees a sulphurous compound added 
in water, has the properties of a disinfectant, but has also 
antibiotic and anti–tumoral effects (Vancanneyt et al., 
2006). The volatile oil obtained from Nasturtium contains, 
in addition to flavonoids, acids from the group of the 
chlorogenic acid, carotenoids, cucurbitacins, proteins, 
aminoacids, sulphur, iron, manganese, phosphoric acid. 
The lipid part that covers the surface of the leaves is 
composed of a mix of aliphatic acids; the main sub-
stances are nonacosanol and nonacosanediol. The T. 
majus flowers are excellent sources of lutein, and the 
leaves contain both lutein and provitamin A and β–
carotene (Luz et al., 2007).  
 
 




The aerial parts (leaves and flowers) of the species T. majus were 
harvested at blossom. Plants were identified and authenticated in 
the Botanical Laboratory of the U.S.A.M.V.B Timisoara. A labelled 
voucher has been kept in the laboratory herbary. The aerial parts of 
the T. majus plant were collected in May 2007 and dried at 18–
22°C for two days. In order to minimize the loss of active 
components, the dehydration was done without thermic treatments. 
After drying, the material was kept at –20°C until it was used 
(Swarna et al., 2009). 
 
 
The extraction method for volatile oils 
 
For the extraction of volatile oil, we used a clevenger type hydro 
distillation device based on the recirculation of water, in order to 
eliminate losses of volatile oil through its solving in the water. The 
heating was done on direct fire, while the installation was 
permanently monitored in order to avoid overheating of the 
distillation container. The vegetal material (500 g) was introduced in 
the balloon of the device after it was weighed, adding 500 ml of 
water; the distillation lasted for 3–4 h. 50 g of finally ground plant 
were extracted with 50 ml of distilled water, methanol 100%, 
ethanol 80% and hexane for 72 h, under intermittent agitation. The 
extracts were than filtered. 
 
 
Evaluating the anti–inflammatory action 
 
Experiments were done on 65 white mice with corporal mass of 
140–200 mg. The animals were distributed in 5 lots. The 
inflammation was induced in all the mice through the injection of 50 
µl 4% formalin under aponeurosis of the back paw. The inflame-
mation degree was determined through the modification of the paw 
volume as could be observed on a graded column of water. The 
first lot of 15 mice was split as follows: 5 mice were administered, 5 
days before the induction of the inflammation, intraperitoneally, 1 
mg of antibiotic (based on chloramphenicol) as suspension; other 5 
mice–3 days before; and the other 5–on the day of the induction of 
the inflammation. 
The second lot of 15 mice was split as follows: 5 mice were 
administered, 5 days before the induction of the inflammation, 
intraperitoneally, 1 mg of antibiotic (based on penicillin) as 
suspension; 5 mice–3 days before; and the other 5–on the day of 
the inflammation. The third lot of  15  mice  was  split  as  follows:  5  




mice were administered, 5 days before the induction of the inflame-
mation, intraperitoneally, 1 mg of antibiotic (based on cephalo-
sporine) as suspension; 5 mice–3 days before; and the other 5–on 
the day of the inflammation. The fourth lot of 15 mice was split as 
follows: 5 mice were administered, 5 days before the induction of 
the inflammation, intraperitoneally, 1 mg of volatile oil obtained from 
Nasturtium, as suspension; 5 mice–3 days before; and the other 5–
on the day of the inflammation. The fifth lot of 5 mice was the 
control lot in which we only induced the inflammation. Measure-
ments were conducted 3, 24 and 48 h after the inflammation was 




Evaluating the antibacterial activity 
 
The standard reference roots (Staphylococcus aureus, Bacillus sp., 
Listeria monocytogenes, Escherichia coli, Salmonella sp., 
Pseudomonas aeruginosa and Candida albicans) used in the 
evaluation of the T. majus volatile oil was provided by the Canta-
cuzino Institute Bucharest. 
The qualitative screening of the susceptibility spectra of different 
microbial strains to the tested compounds was performed by 
adapted diffusion techniques. We used filter paper discs 
impregnated with solutions of the tested substances and the 
repartition in spot of the tested substances on solid media seeded 
in canvass. The study of the antimicrobial properties by the adapted 
disk diffusion method–Petri dishes with Mueller Hinton (for bacterial 
strains)/YPG (Yeast Peptone Glucose) (for yeasts) medium were 
seeded with bacterial inoculum as for the classical antibiotic 
susceptibility testing disk diffusion method (CLSI); 5 mm diameter 
paper filter disks were placed on the seeded medium, at 30 mm 
distance. Subsequently, the disks were impregnated with 5 ml of 
compound solution; by method Clinical and Laboratory Standards 
Institute (2007). 
The study of the antimicrobial properties by spotting the tested 
solution on the culture medium seeded with the microbial 
suspension, the antimicrobial activity being expressed as the 





The quantitative assay of minimal inhibitory concentration (M.I.C., 
µg/ml) value was based on liquid medium serial micro dilutions. 
Serial binary dilutions of the tested compounds (ranging between 
1024 and 8 mg/ml) were performed in a 200 ml volume of nutrient 
broth and each well was seeded with 50 ml of microbial inoculum 
(0.5 McFarland density). The plates were incubated for 24 h at 
37°C, and MICs were read as the lowest concentration of 
compound which inhibited the microbial growth; by method Clinical 
and Laboratory Standards Institute (2006). The standard culture 
environments came from I. Cantacuzino. Every environment box 
comes with quality control certificates. 
These certificates enumerate the testing organisms, including the 
ATCC cultures specified in the CLSI M22 standard Quality control 
for commercialized culture environment preparates. The time 
interval for detection was ≤72 h for each of the organisms 
enumerated in the quality control certificate of this environment; by 
method FDA. (2006). 
The decisive test local application; day 20–22, control and 
treatment groups. The ribs of the animals from the control and 
treatment groups were shaved of hair. A compression soaked in the 
test substance (volatile oil of T. majus) is applied on a single rib of 
the mouse and another compression soaked only in the vehicle can 
also be applied on the other rib. The compressions are kept in 
contact with the skin through occlusive gauze for 24 h. Control and 





been removes; the tested zone is cleaned and carefully shaved, if 
necessary. 
Approximately 3 h later (so approximately 48 h from the 
beginning of the application) the cutaneous reaction is registered 
and observed according to the degrees showed. Approximately 24 
h after this observation, we make a second observation (at 72 h) 
and another recording. We recommend both on the control and the 
treatment lots. The graded Magnusson and Kligman scale for the 
evaluation of reactions to the application of the compression: 0=no 
visible change; 1=small or irregular erythema; 2=moderate and 
confluent (adherent) erythema; 3=intense and swollen erythema 
(U.S. Department, 2007). The Institutional Animal Care approved all 
of the experimental protocols. The number of experimental animals 





Results were analyzed using Student’s t–test and expressed as 
mean± SEM. Differences between the mean of treated animals and 
control groups were considered significant at P<0.05. 
 
 
RESULTS AND DISCUSSION 
 
The analysis of the volatile oil 
 
The preliminary phytochemical investigation of the 
aqueous extracts of the T. majus, preliminary results 
showed that it contains volatile oils and terpenoids, 
saponins, tannins, glycosides, alkaloids, fatty acids and 
antibiotic–tromalyt. The vegetable material composed of 
a mix of flowers and leaves of T. majus underwent hydro 
distillation and extraction with inorganic and organic 
solvents respectively. For the qualitative phytochemical 
analysis, we obtained extracts and volatile oil that were 
then used for the evaluation of their anti-inflammatory 
and antimicrobial potential. The qualitative reactions high-
lighted the fatty acids, sterols, flavonoids, free sugars, 
organic acids, tannins, alkaloids, saponoids and poly-
saccharides (Table 1). 
The natural compounds of the isolated volatile oil have 
been identified and determined quantitatively, through 
gas–chromatographic analysis coupled with mass 
spectrometry. For this, we separately evaluated the aerial 
parts of the plants. We determined 450±50 µg/g lutein in 
the yellow–colored flowers and 350±60 µg/g lutein in the 
orange–colored flowers. In the volatile oil obtained from 
the aerial parts, we also detected 136±18 µg/g lutein, 
69±7 µg/g β–caroten, 74±23 µg/g violaxanthin, 24±3 µg/g 
hetero–transglicosilatin and 48±13 µg/g neoxanthin. 
Violaxanthin, antheraxanthin, zeaxanthin, zeinoxanthin, 
β–cryptoxanthin, α–caroten, and β–caroten were detec-
ted in small concentrations in all cases. Results indicated 
the fact that there are no significant differences among 
extracts obtained from leaves or flowers from the point of 
view of the types of compounds detected. 
Therefore, the mixture of all the aerial parts of the plant 
was considered optimal for the purpose of this study. 
Saponins are present on average 2.153±0.07%. Chroma-
tographic  analysis  shows  that  saponins  from  T. majus  




Table 1. Results of phytochemical screening of T. majus. 
 
S/N Group Phytochemical reaction 
1 Saponins  present 
2 Steriods  present 
3 Tannins present 
4 Glycosides present 
5 Alkaloids present 
6 Fatty acids present 
7 Flavanoids  present 
8 Polyzaharides present 




represent the sum of ester–saponins, bisdesmosides and 
monodesmosides of hederagenol (Figure 1). Fatty acids, 
such as palmitic oleic, stearic or docosanoic acid, were 
present in a concentration of 9.5± 0.12%, sterols 6.6± 
0.1%, and esther sterols 8.4± 0.01%. 
 
 
The anti–inflammatory effect of volatile oil 
 
Results presented in Table 2 shows that metabolites from 
volatile oil extracted through hydro distillation from T. 
majus prevents inflammation and influences its degree of 
manifestation, especially after 24 and 48 h. The degree of 
manifestation is more reduced in mice which were 
administered T. majus volatile oil, as compared to those 
having been treated with synthesised products. The anti-
inflammatory effects of the volatile oil extracted through 
hydro distillation from T. majus are explained by the 
presence of tiosulphinates. These compounds have the 
capacity to inhibited synthesis and the release of some 
pro–inflammatory mediators. Comparative analysis bet-
ween the anti-inflammatory potential of the T. majus 
volatile oil and other classical anti-inflammatory shows a 
strong anti-inflammatory activity in the case of the first, 
where we could observe a complete resorption within 48 
h from administration (Table 3). This action seems to be 
caused mainly by the saponoids identified in the volatile 
oil (Figure 1), but also to the content of lecithin’s, acetil-
balcanolids and the asulenes from the volatile oil. 
Another category of natural compounds comprised in the 
volatile oil is that of lactones, sesquiterpens, polynesians 
and polyphenols, which have as effect the inhibition of 
the development of the induced edema (Table 3). 
 
 
Testing of anti-irritant and anti-inflammatory effect of 
T. majus volatile oil 
 
Sodium lauryl sulphate (SLS) is a well-known tension-
active agents used as an irritation model. This substance 
determines important toxic effects at skin level; the 
intensity of the effect depends  on  the  relationship dose- 
effect. Its primary effects are the production of erythema 
and edema. Concentrations above 10% are harmful for 
the skin, especially when it is applied as sole compound. 
The T. majus volatile oil has been used directly on the 
skin immediately after the irritation was induced with SLS. 
The experimental mice lot on which the anti-irritant effect 
was tested is presented under the methods section. Vola-
tile oil containing natural substances from T. majus 
presented a remarkable activity of inflammation reduction 
of up to 85%. The results of the visual evaluation of the 
potential to reduce irritation with SLS are shown in Table 
4. In order to evaluate the effects of volatile oil, the 
aspect of the skin was monitored visually at certain time 
intervals. 
At the visual evaluation of the skin appearance (Table 
5) after the application of the preparation containing T. 
majus volatile oil, compared to other classical anti-
inflammatory preparations, we observed that the integrity 
of the hydric layer of the skin was significantly improved 
right after the application of the product (30 min). The 
phytochemical study demonstrated the presence in the T. 
majus volatile oil and extracts of some metabolites that 
present antimicrobial property (tannins and flavonoids).  
 
 
Testing of antimicrobial action of T. majus volatile oil 
 
The antimicrobial action is determined by the phenols 
and metil–ethers identified in the T. Majus extracts, but 
also by the tymol and carvacrol present in the volatile oil. 
The volatile oils tested presented a wide range of 
action over both Gram-positive and Gram–negative spe-
cies (Tables 6 and 7). Among the qualitative methods 
employed for the control of the antimicrobial activity, the 
method of diffusion on filter paper disk proved to be most 
efficient, the results correlating well with MIC (Table 6). In 
the case of the quantitative analysis of the antimicrobial 
activity of the compounds tested through the method of 
the micro dilutions in a liquid environment, the develop-
ment of the microbial cells was stopped by all the tested 
compounds (Table 7). At smaller concentrations (256 µl 
essential oil) of natural compounds, the  microbial  culture  






Figure 1. The Chromatogram of hydro–distilled extract from Tropaeolum Majus each peak represents one of 
the detected compounds: fatty acids (1–palmitic acid, 2–stearic acid, 3–oleic acid, 4–linoleic acid and 5–
linolenic acid) 6–docosahexaenoic acid; 7–sterols, 8–sterol esters; carotenoid pigments (9– lutein; 10–beta 
carotene; 11–violaxanthin); 12–hetero–transglicosilating; 13– neoxanthin; 14–saponins; 15–bis–




Table 2. The evaluation of the efficiency of volatile oil compounds’ on the evolution of the inflammatory process. 
 
Preparation 
Time of measurement 
3 h 24 h 48 h 
Preparation based on 
chloramphenicol 
Administration 5 days before the 
inflammation was induced. 0.082 ml 0.075ml 0.045 ml 
Administration 3 days before the 
inflammation was induced. 0.086 ml 0.08 ml 0.046 ml 
Administration on the day when the 
inflammation was induced. 0.11 ml 0.09 ml 0.09 ml 
     
T. Majus volatile oil 
Administration 5 days before the 
inflammation was induced. 0.132 ml 0.96 ml 0.024 ml 
Administration 3 days before the 
inflammation was induced. 0.083 ml 0.080 ml 0.06 ml 
Administration on the day when the 
inflammation was induced. 0.1 ml 0.08 ml 0.00 ml 
     
Preparation based on 
penicillin  
Administration 5 days before the 
inflammation was induced. 0.12 ml 0.11ml 0.09 ml 
Administration 3 days before the 
inflammation was induced. 0.113 ml 0.1 ml 0.086 ml 
Administration on the day when the 
inflammation was induced. 0.11 ml 0.11 ml 0.09 ml 
     
Preparation based on 
cephalosporine  
Administration on the day when the 
inflammation was induced. 0.114 ml 0.1 ml 0.056 ml 
Control 0.1 ml 0.11 ml 0.09 ml 




Table 3. Percents of inhibition of the inflammatory edema for the studied substances. 
 
Preparation 
Dose mg / kg 
body mass 
Edema inhibition 
after 2 h % 
Edema inhibition 
after 4 h % 
Edema inhibition 
after 24 h % 
Distilled water – – – – 
Preparation based on chloramphenicol 1.4 28.57 48.71 34.41 
T. majus volatile oil 1.4 31.42 18.20 11.18 




Table 4. Visual evaluation of the effects of volatile oil in the reduction of irritation produced by SLS. 
 
Preparation T. majus volatile oil 
Preparation based on 
chloramphenicol 
Preparation based on 
penicillin 
Witness 
Erythema 0 0.5 1 0 
     
Desquamation 0 0 0 0 
     
Edema – – – – 
     
% of mice with  
a positive response 
85% 75% 25% 100% 
     
Observations 
15% of the subjects 
presented redness, 
which disappeared within 
an hour after the 
application of the 
preparation 
25% of the tested subjects 
presented edema or diffuse 
redness or symptoms that 
disappeared several hours after 
the application of the 
preparation 
80 % of the tested 
subjects presented very 
evident edema, skin 
irritation, erythema that 
persisted for 24 h 
– 
 




Table 5. Visual evaluation of the appearance of the irritated skin after the application of the T. majus volatile oil treatment. 
 
Preparation after 30min after 1h after 3h after 5h Observation 
T. majus volatile oil 
+60% 
(9 out of 15) 
+50% 
(3 out of 6) 
+66.6% 
(2 out of 3) 
0% 
(1 out of 1) 
The integrity of the hydric layer 
was improved right after the 
application of the product; the 
effect persists more than 3 h 




(2 out of 15) 
+15.38% 
(2 out of 13) 
+45.45% 
(5 out 11) 
Does not vary 
This preparation changes 
significantly the hydric barrier 
functions of the skin 
      
Preparation based 
on penicillin  
–35% 
(4 out of 15) 
–70% 
(2 out of 11) 
–15% 
(3 out of 9) 
Does not vary 
We observe a hydric degrading, 
correlated to an even greater 
evaporation of water in the first 
hour after the application of the 
product 
 




becomes visible. In the case of smaller concentrations 
than 256 µl, the microbial cultures grow. Regarding the 
qualitative analysis of the CMI values, the most active 
compounds from the first series (Table 6) proved to be 
those from the mix containing 1024 µl, respectively 512 µl 
volatile oil, which presented an antimicrobial action 
against all tested species, with a constant value of CMI of 
256 micrograms / ml. The followers are the  mixes  of  the  




Table 6. Antimicrobial susceptibility pattern of essential (10 µl/disc) oil, aqueous solution, methanol extract, ethanol extract and n–
hexane extract (300 µg/disc) of T. majus. 
 
Microorganism 
Inhibition zone diameter (mm) Synergistic activity 













E. coli 28 ± 0.5 13 ± 0.5 18 ± 0.3 16 ± 0.4 17 ± 0.3 36 ± 0.5 
Salmonella sp. 24 ± 0.5 11 ± 0.5 19 ± 0.5 20 ± 0.5 22 ± 0.5 34 ± 0.5 
P. aeruginosa 29 ± 0.5 12 ± 0.3 16 ± 0.5 23 ± 0.5 19 ± 0.5 32 ± 0.5 
       
Gram (+) 
L. monocytogenes 34 ± 0.5 19 ± 0.5 21 ± 0.2 25 ± 0.5 21 ± 0.3 35 ± 0.7 
S.  aureus 29 ± 0.5 10 ± 0.3 18 ± 0.3 19 ± 0.4 23 ± 0.5 35 ± 0.7 
B. subtilis 27 ± 0.4 19 ± 0.3 17 ± 0.4 16 ± 0.3 22 ± 0.3 31 ± 0.5 
       
Diploid fungus (a form of yeast) 
C. albicans 35 ± 0.5 23 ± 0.5 19 ± 0.5 22 ± 0.5 12 ± 0.3 42 ± 0.7 
 




second series, the 512 µl volatile oil mix with the 512 µl 
methanolic extract of T. majus; the 512 µl volatile oil with 
the 512 µl ethanolic extract of T. majus; and the 256 µl 
volatile oil and 256 µl hexanolic extract of T. majus. All 
these present a good antimicrobial action against the 
majority of the tested species, except for E. coli and S. 
aureus (CMI varying between 64–256 micrograms/ml). 
The other mixes tested presented variable levels and 
ranges of antimicrobial action. The microorganism that is 
most sensitive to the action of the tested natural 
compounds of T. majus proved to be P. aeruginosa and 
C. albicans, followed by Salmonella sp. and Bacillus sp, 
while the most resistant is the E. coli stem. 
The activity of these oils over the Gram–positive 
bacteria included in the test was superior or similar to the 
action of standard antibiotics ampicillin and chloram-
phenicol. All the tested oils presented an antifungical 
action similar or better than the action of the standard 
benchmarks carvacrol and tymol. Volatile oil seems to be 
active in the 1024 and 512 µl concentrations employed. 
The aqueous extract of T. majus presented a weak 
action, whereas the alcoholic and hexane extracts of the 
same plant proved to be active. We observed an 
antilevuric action of the same concentrations, but also of 
the mixes of volatile oil and extracts, both alcoholic and 
hexanic, except the mix of volatile oil and extract 
aqueous of T. majus. The volatile oil obtained as descry-
bed in the previous paragraphs is applied on the mouse 
model with cutaneous irritation and the evolution of the 
area is observed in time. After a few applications, we can 
observe a visible improvement. 
Table 8 compares the treatment with T. majus volatile 
oil with the use of other pharmaceutical products that 
contain zinc compounds (such as zinc oxide and zinc 
sulphate) used as antimicrobial. This behaviour is ex-
plained through the complexation of proteins by the 
tannins contained by the T. majus volatile oil, which leads 
the tissue to become denser, to contract, so that the 
surface of the lesion concentrates and the capillaries’ are 
obturated, which leads to local homeostasis. At the 
surface of the skin, a film of protein–tannins gets formed, 
impermeable and unbootable, which determines a 
diminution of secretions and, therefore, the local irritation 
is reduced. 
The same film protects the nervous terminations by the 
action of some irritant stimuli, which explains the slightly 
local aesthetic effect. In the case of the product based on 
the T. majus volatile oil, it can be seen in the table 
pointing out the cutaneous reactions of erythema and 
escares: the result is 0, like for the formation of edema. 
The growth of the number of types of bacteria resistant 
to classical chemotherapeutics and antibiotics (including 
penicillin) has imposed the necessity to investigate alter-
native ways in antibiotic therapy. The discovery of plants 
with potentially antimicrobial properties opened a new 
horizon in this field. 
The tests done to evidence the antimicrobial action 
showed that the majority of the used solutions derived 
from the initial extract from T. majus volatile oil present 
low CMI values (mg/ml), which demonstrates an efficient 
antimicrobial and anti-inflammatory action. Based on 
these results, it was possible to demonstrate that the 
presence of cardiotonic glycosides in the T. majus volatile 
oil renders the volatile oil and it’s aqueous, alcoholic and 
hexanes’ extracts an anti-inflammatory and antimicrobial 
potential, our results being in line with specialty literature 
(Directive, 2000). The positive results are connected to 
the presence of tannins and saponins in the T. majus 
volatile oil. On local application, the tannins act as astringents, 
healing,   antiexudative,  anti–irritative,  anti-inflammatory, 




Table 7. Minimal inhibitory concentration (MIC) of the natural compounds obtained from T. majus on the various microbial stems, using the 
micro dilution method. 
 
Essential oil volume 















Solvent µl oil Inhibitory potential MIC/MBC (µg/ml) series I 
DMSO 1024 256±0.12 256±0.37 256±0.11 256±0.14 256±0.05 256±0.24 256±0.15 
DMSO 512 256±0.08 256±0.21 256±0.5 256±0.24 256±0.17 256±0.12 256±0.23 
DMSO 256 512±0.15 >1024 256±0.11 1024 512 >1024 1024 
DMSO 128 512±0.43 >1024 >1024 >1024 >1024 >1024 >1024 
DMSO 64 1024 >1024 >1024 >1024 >1024 >1024 >1024 
DMSO 32 1024 1024 1024 >1024 1024 256±0.18 >1024 
DMSO 16 1024 1024 1024 >1024 1024 256±0.21 512 
DMSO 8 >1024 >1024 >1024 >1024 >1024 256±0.20 >1024 
         
Extract (µl) Inhibitory potential MIC/MBC (µg/ml) series II 
Hexane extract 1024 256±0.17 256±0.12 32±0.12 >1024 32±0.24 >1024 64±0.18 
Methanol extract 1024 128±0.02 256±0.17 32±0.20 >1024 >1024 >1024 128±0.40 
Ethanol extract 1024 1024 256±0.14 32±0.02 >1024 32±0.23 >1024 128±0.40 
Aqueous extract 1024 512 512 32±0.01 1024 32±0.08 >1024 1024 
Aqueous extract 512 >1024 >1024 256±0.06 >1024 >1024 >1024 256±0.35 
Aqueous extract 512 >1024 >1024 256±0.03 >1024 >1024 >1024 256±0.14 
Methanol extract 512 >1024 256±0.03 256±0.21 256±0.22 >1024 256±0.13 128±0.09 
Ethanol extract 512 >1024 256±0.04 256±0.04 256±0.15 >1024 128±0.15 64±0.40 
Hexane extract 256 >1024 256±0.05 256±0.05 256±0.20 >1024 128±0.23 64±0.25 
Methanol extract 256 >1024 >1024 256±0.17 128±0.05 >1024 >1024 128±0.03 
Ethanol extract 256 >1024 >1024 >1024 >1024 >1024 >1024 256±0.15 
Aqueous extract 256 >1024 >1024 >1024 >1024 >1024 >1024 >1024 
DMSO  256 256 256 256 256 256 256 
 




Table 8. Comparison between the treatment with T. majus volatile oil and other pharmaceutical compounds. 
 
Edema formation 
Number of day 
Serious edema Moderate edema Light edema Very light edema No edema 
Product used day day day day day day 
Product A 0 3 5 6 7 10 
Product B 0 4 5 5 7 8 
T. majus volatile oil 0 2 3 4 5 7 
       
Results 
 
Product A 2 – 3 
Product B 2 




antiseptic, anesthesic and antioxidant. Tannins form com-
plexes with the proteins from the superficial layers of the 
skin, leading to the formation of a protective layer of 
protein-tannins. Moreover, the tannins act as antiseptics 
through the precipitation of the proteins from the 
membrane of the microorganisms and anti-inflammatory 
through the inhibition of the synthesis of prostaglandins 
and the freeing of the plachetary activating factor (PAF) 
(Mahesh et al., 2008). Saponins, which from a structural 
point of view are glycosides, have an antiseptic and anti-
microbial action, in a non-harmful way for the neighboring 
cellular tissues. The  specialty  literature  draws  attention  to  




the presence of flavonoids in the leaves of T. majus. The 
compounds form the volatile oil can have various 
reactions depending on the concentration of these 
metabolites, which in turn depends on the extraction 
conditions, the place in which the plant was cultivated or 
the timeframe in which it was cropped (Akinmoladun et 
al., 2007). Flavonoic derivates develop anti-inflammatory 
effects (mainly by inhibiting the freeing of lisosomal 
enzymes and reducing the level of oxygen–reactive 
species) (Casadevall et al., 2001), anti–allergic effects 
(by inhibiting the classical way the seric complement is 
activated), anti-microbial, capillary-protective and anti-
oxidant effects (FDA, 2006). Although, the antimicrobial 
properties of the volatile oils and their components have 
been studied in the past, the mechanism of their action 
has never been studied in detail (Arai et al., 2005). 
Taking into account the large number of the different 
groups of chemical compounds present in the com-
position of the volatile oils, it is very possible that their 
antimicrobial activity cannot be assigned to a sole 
mechanism (Flayhart, 2007), but to the existence of a 
large number of target locations in the cell. Not all these 
mechanisms represent separate targets; some are 
consequences of other target mechanisms (Chatterjee et 
al., 2010). The chemical structure of the individual com-
pounds of volatile oils affects in their specific ways the 
antibacterial action. 
Thus, the presence and the position of the hydroxyl 
group among the phenolic acids like carvarol and thymol 
affects to a wide extent the degree of the antibacterial 
action. 
The anti-infectious/antimicrobial action of the T. majus 
volatile oil is to a great extent given by the esthers of the 
phenolic acids with aromatic alcohols (Harris et al., 
2010).  
The cetones, other natural compounds of the T. majus 
volatile oil, have important actions over organisms (Nam 
and Jin, 2010), such as anti–infectious action 
(antibacterial, antiviral, antifungic, antiparasitary) (Paus et 
al., 2006), an action based on the biological nucleophilia 
of cetones towards the amino and tyol groupings, more 
exactly towards some active situses of some enzymes 
essential to their lives, inducing irreversible alchilations 
which lead to the interruption of the multiplication of the 
infectious agents (Peters et al., 2005).  
Phenolic heterosides, contained in the T. majus volatile 
oil, (Jentschel et al., 2007) have the role of solubilising 
lipophilic metabolites (Ribeiro et al., 2007) so that these 
can then diffuse from the plasma to the vacuoles or 
through  the  cellular  membranes,  reaching  the  reserve 





We have approached several methods to obtain natural 





the extract with the best biological action. Results 
indicated the fact that there are no significant differences 
between the extracts obtained from leaves or flowers 
regarding the detected compounds, so the mix of the 
aerial parts of the plant was considered optimal for 
ulterior analysis. 
Following the investigations on the volatile oil obtained 
from the aerial parts of the T. majus species, we 
highlighted the characteristic compounds with antimicro-
bial and anti-infectious properties. We obtained and 
characterised through chromatographic methods the 
following series of compounds: Fatty acids, docosahe-
xaenoic acid, sterols, sterol esters, carotenoid pigments, 
hetero–transglicosilating; neoxanthin; saponins; bis–
desmosides; mono–desmosides; hederagenol; flavonoids; 
tromalyt and tannins. From the qualitative methods used 
to control the antimicrobial activity, the method of 
diffusion on filter paper disc proved most efficient, with 
results correlating well with the MIC. In the case of the 
quantitative analysis of the antimicrobial analysis of the 
compounds tested through the micro dilution in liquid 
environment method, the development of the microbial 
cells was stopped by all the tested compounds. At lower 
concentrations (256 µl essential oil) of natural com-
pounds, the microbial culture becomes visible. The 
studied effects show that the majority of the used 
solutions derive from the initial extract of T. majus volatile 
oil present low CMI values (mg/ml), which demonstrated 
an efficient antimicrobial action. Thiosulphinates act as 
antimicrobials’ and anti-inflammatory. The antimicrobial 
activity of the thiosulphinates has been explained through 
their possibility to react with the –SH groupings of the 
bacterial proteins, the result being the perturbation of the 
bacterial metabolism and, finally, the death of the bacterial 
cell. The anti-inflammatory effects of the thiosulphinates 
originate in their capacity to inhibit the synthesis and the 
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